Author

Mauricio Hernández

ORCID 0000-0002-2277-0132Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Benjamin Lozano· 1 shared Cristian VargasiD· 1 shared Daniela Villalobos· 1 shared Elard S. KochiD· 1 shared Elizabeth RivasiD· 1 shared Estefanía Nova-LampertiiD· 1 shared Graciela BravoiD· 1 shared Jaime RetamaliD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Benjamin Lozano

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Tocilizumab induces significant changes in longitudinal proteomes of blood serum from patients with severe COVID-19 pneumonia

José Cordero, Graciela Bravo, Pedro H. Silva, Benjamin Lozano, Elizabeth Rivas, Valeria Labra, Daniela Villalobos, Pablo Saldivia, Mauricio Hernández, Elard S. Koch, Cristian Vargas, Estefanía Nova-Lamperti, Nelson P. Barrera, Jaime Retamal

This study shows that tocilizumab reduces inflammation in severe COVID-19 by altering serum proteomes, restoring protein levels to healthy states.

bioRxiv · May 6, 2026 · PreprintPharmacology & Toxicology